Mobia Medical, Inc MOBI
—
9.06
0.25
2.84%
as of 25 Sep
- Market cap
- $293.3M
- P/E
- 0.0×
Follow MOBI
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | — | — | — |
+2 more TTM periods Free account |
|
| (61.37%) | 0.00% | — | — | ||
ROIC |
(1,242.56%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(33.34%) | 0.00% | 0.00% | — | |
Average Days of Receivables |
54.53 | 0.00 | 0.00 | — | |
Free Cash Flow per Share |
(4.82) | (92.03) | 0.00 | 0.00 | |
Free Cash Flow |
(92.04) | (84.57) | (91.16) | — | |
Capital Expenditures |
(1.95) | (0.43) | (0.43) | — | |
Piotroski F-Score |
0.00 | — | — | — | |
| Other line items | |||||
Cash ROIC |
(25.24%) | (72.70%) | (130.14%) | 0.00% | |
Accounts Receivable Turnover |
0.00 | — | — | — | |
Accounts Payable Turnover |
0.00 | — | — | — | |
Inventory Turnover |
0.00 | — | — | — | |
Average Days of Payables |
130.48 | 0.00 | 0.00 | — | |
Days of Inventory on Hand |
384.36 | 0.00 | 0.00 | — | |
Tax Rate |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
17.78% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
211.53% | — | — | — | |
Share Based Compensation of Revenue |
6.91% | — | — | — | |
Interest Coverage |
0.00 | — | — | — | |
Operating CF/Net income |
1.50 | 0.00 | 0.00 | — | |
Depreciation/Fixed assets |
0.28 | 0.61 | 0.63 | — | |
Capex/Depreciation |
(3.42) | (0.95) | (1.02) | — | |
Revenue per Share |
1.99 | 0.00 | — | 0.00 | |
Operating CF per Share |
(4.72) | (91.56) | 0.00 | 0.00 | |
Capex per Share |
(0.10) | (0.47) | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.00 | 0.00 | — | |
Net Profit Margin |
(158.06%) | — | — | — |
Columns are period end dates